Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox Driven Racemic Epinephrine Nebulization in Pediatric Bronchiolitis
NCT00116584Phase 3Completed
- Sponsor
- University of Louisville
- Start
- Dec 2004
- Primary completion
- Mar 2008
- Modality
- GAS (Genetic analysis systems)
- Countries
- 1
01
Overview
Phase 3, randomised trial of heliox in bronchiolitis (2 arms), sponsored by University of Louisville. Primary endpoint: Change in Modified Wood's Clinical Asthma Score at 240 minutes. Started Dec 2004; status: completed.
02
Drugs
heliox
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT00116584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116584.